JD Health International Inc. (HKG:6618)
Hong Kong · Delayed Price · Currency is HKD 67.30
-0.45 (-0.66%)
Sep 25, 2025, 3:25 PM HKT
JD Health International Market Cap
JD Health International has a market cap or net worth of 216.90 billion as of September 24, 2025. Its market cap has increased by 194.94% in one year.
Market Cap
216.90B
Enterprise Value
163.35B
Revenue
71.34B
Ranking
n/a
PE Ratio
41.76
Stock Price
67.30
Market Cap Chart
Since December 8, 2020, JD Health International's market cap has decreased from 343.98B to 216.90B, a decrease of -36.94%. That is a compound annual growth rate of -9.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2025 | 216.90B | 141.32% |
| Dec 31, 2024 | 89.88B | -27.91% |
| Dec 29, 2023 | 124.67B | -45.05% |
| Dec 30, 2022 | 226.89B | 15.58% |
| Dec 31, 2021 | 196.31B | -58.90% |
| Dec 31, 2020 | 477.66B | 38.86% |
| Dec 8, 2020 | 343.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 288.97B |
| Hansoh Pharmaceutical Group Company | 214.07B |
| WuXi Biologics | 162.88B |
| Innovent Biologics | 162.20B |
| Sino Biopharmaceutical | 145.58B |
| Akeso | 125.83B |
| Sichuan Kelun-Biotech Biopharmaceutical | 122.54B |
| CSPC Pharmaceutical Group | 113.64B |